314 related articles for article (PubMed ID: 14712209)
1. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells.
Liu T; Brouha B; Grossman D
Oncogene; 2004 Jan; 23(1):39-48. PubMed ID: 14712209
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P
Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775
[TBL] [Abstract][Full Text] [Related]
3. Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels.
Kominsky DJ; Bickel RJ; Tyler KL
J Virol; 2002 Nov; 76(22):11414-24. PubMed ID: 12388702
[TBL] [Abstract][Full Text] [Related]
4. Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways.
Zhang XD; Gillespie SK; Hersey P
Mol Cancer Ther; 2004 Feb; 3(2):187-97. PubMed ID: 14985459
[TBL] [Abstract][Full Text] [Related]
5. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
6. Activation of dual apoptotic pathways in human melanocytes and protection by survivin.
Liu T; Biddle D; Hanks AN; Brouha B; Yan H; Lee RM; Leachman SA; Grossman D
J Invest Dermatol; 2006 Oct; 126(10):2247-56. PubMed ID: 16728972
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.
Chawla-Sarkar M; Bae SI; Reu FJ; Jacobs BS; Lindner DJ; Borden EC
Cell Death Differ; 2004 Aug; 11(8):915-23. PubMed ID: 15118763
[TBL] [Abstract][Full Text] [Related]
8. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
9. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Sox-4 in the cytochrome c-dependent AIF-independent apoptotic pathway in HeLa cells induced by Delta12-prostaglandin J2.
Kim BE; Lee JH; Kim HS; Kwon OJ; Jeong SW; Kim IK
Exp Mol Med; 2004 Oct; 36(5):444-53. PubMed ID: 15557816
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.
Yang L; Cao Z; Yan H; Wood WC
Cancer Res; 2003 Oct; 63(20):6815-24. PubMed ID: 14583479
[TBL] [Abstract][Full Text] [Related]
12. Mathematical modeling of the regulation of caspase-3 activation and degradation.
Stucki JW; Simon HU
J Theor Biol; 2005 May; 234(1):123-31. PubMed ID: 15721041
[TBL] [Abstract][Full Text] [Related]
13. Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis.
Carter BZ; Kornblau SM; Tsao T; Wang RY; Schober WD; Milella M; Sung HG; Reed JC; Andreeff M
Blood; 2003 Dec; 102(12):4179-86. PubMed ID: 12920030
[TBL] [Abstract][Full Text] [Related]
14. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma.
Nachmias B; Ashhab Y; Bucholtz V; Drize O; Kadouri L; Lotem M; Peretz T; Mandelboim O; Ben-Yehuda D
Cancer Res; 2003 Oct; 63(19):6340-9. PubMed ID: 14559822
[TBL] [Abstract][Full Text] [Related]
15. Bisphenol A diglycidyl ether-induced apoptosis involves Bax/Bid-dependent mitochondrial release of apoptosis-inducing factor (AIF), cytochrome c and Smac/DIABLO.
Fehlberg S; Gregel CM; Göke A; Göke R
Br J Pharmacol; 2003 Jun; 139(3):495-500. PubMed ID: 12788809
[TBL] [Abstract][Full Text] [Related]
16. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
[TBL] [Abstract][Full Text] [Related]
17. Loss of inhibitor of apoptosis proteins as a determinant of polyamine analog-induced apoptosis in human melanoma cells.
Chen Y; Kramer DL; Li F; Porter CW
Oncogene; 2003 Aug; 22(32):4964-72. PubMed ID: 12902979
[TBL] [Abstract][Full Text] [Related]
18. Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells.
Kang DW; Choi CH; Park JY; Kang SK; Kim YK
Neurochem Res; 2008 Mar; 33(3):551-61. PubMed ID: 17940898
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
[TBL] [Abstract][Full Text] [Related]
20. Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist.
Yan H; Thomas J; Liu T; Raj D; London N; Tandeski T; Leachman SA; Lee RM; Grossman D
Oncogene; 2006 Nov; 25(52):6968-74. PubMed ID: 16702945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
